These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 397210)

  • 21. A clinicopathologic analysis of adriamycin cardiotoxicity.
    Lefrak EA; Pitha J; Rosenheim S; Gottlieb JA
    Cancer; 1973 Aug; 32(2):302-14. PubMed ID: 4353012
    [No Abstract]   [Full Text] [Related]  

  • 22. Heart of darkness: the downside of trastuzumab.
    Hayes DF; Picard MH
    J Clin Oncol; 2006 Sep; 24(25):4056-8. PubMed ID: 16908930
    [No Abstract]   [Full Text] [Related]  

  • 23. Reduced cardiotoxicity and preserved antitumor efficacy of liposome-encapsulated doxorubicin and cyclophosphamide compared with conventional doxorubicin and cyclophosphamide in a randomized, multicenter trial of metastatic breast cancer.
    Batist G; Ramakrishnan G; Rao CS; Chandrasekharan A; Gutheil J; Guthrie T; Shah P; Khojasteh A; Nair MK; Hoelzer K; Tkaczuk K; Park YC; Lee LW
    J Clin Oncol; 2001 Mar; 19(5):1444-54. PubMed ID: 11230490
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Cardiotoxicity as undesired side effect in the treatment of breast cancer].
    Gramatyka M
    Postepy Hig Med Dosw (Online); 2014 May; 68():483-97. PubMed ID: 24864100
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Antibiotic and anti-cancer pasting for putrefactive cancers].
    Okuyama S; Ishibashi C; Sato A; Mishina H
    Gan To Kagaku Ryoho; 1995 Oct; 22(12):1851-3. PubMed ID: 7574822
    [No Abstract]   [Full Text] [Related]  

  • 26. Late, late doxorubicin cardiotoxicity.
    Gottlieb SL; Edmiston WA; Haywood LJ
    Chest; 1980 Dec; 78(6):880-2. PubMed ID: 7449470
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adriamycin (doxorubicin) cardiotoxicity: a review.
    Chlebowski RT
    West J Med; 1979 Nov; 131(5):364-8. PubMed ID: 394479
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Postradiotherapy myocardiopathy. Report of a case].
    Lupi E; Bialostozky D; Marcuschamer J; García H; Soní J
    Arch Inst Cardiol Mex; 1974; 44(3):487-99. PubMed ID: 4846496
    [No Abstract]   [Full Text] [Related]  

  • 29. [Cardiotoxicity induced by radiotherapy].
    Cocchieri M; Ramoni N; Severini D
    Minerva Cardioangiol; 1993 Apr; 41(4):119-22. PubMed ID: 8332266
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chemotherapy for stage III-IV epithelial ovarian cancer with cis-dichlorodiammineplatinum(II), adriamycin, and cyclophosphamide: a preliminary report.
    Ehrlich CE; Einhorn L; Williams SD; Morgan J
    Cancer Treat Rep; 1979 Feb; 63(2):281-8. PubMed ID: 376134
    [No Abstract]   [Full Text] [Related]  

  • 31. [Electrocardiogram analysis of adriamycin cardiotoxicity in 160 cases].
    Wang SQ
    Zhonghua Zhong Liu Za Zhi; 1991 Jan; 13(1):71-3. PubMed ID: 1889343
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Efficacy of cardiac monitoring with echocardiography in adult patients receiving adriamycin].
    Okada Y; Sano M
    Gan To Kagaku Ryoho; 2003 Jun; 30(6):823-7. PubMed ID: 12852350
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Doxorubicin and paclitaxel, a highly active combination in the treatment of metastatic breast cancer.
    Dombernowsky P; Gehl J; Boesgaard M; Paaske T; Jensen BV
    Semin Oncol; 1996 Oct; 23(5 Suppl 11):23-7. PubMed ID: 8893895
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adriamycin combinations in advanced breast cancer. A Southwest Oncology Group Study.
    Tranum BL; McDonald B; Thigpen T; Vaughn C; Wilson H; Maloney T; Costanzi J; Bickers J; el Mawli NG; Palmer R; Hoogstraten B; Heilburn L; Rasmusen S
    Cancer; 1982 Mar; 49(5):835-9. PubMed ID: 7037152
    [No Abstract]   [Full Text] [Related]  

  • 35. Phase II evaluation of adriamycin in human neoplasia.
    O'Bryan RM; Luce JK; Talley RW; Gottlieb JA; Baker LH; Bonadonna G
    Cancer; 1973 Jul; 32(1):1-8. PubMed ID: 4716773
    [No Abstract]   [Full Text] [Related]  

  • 36. Pegylated liposomal doxorubicin and trastuzumab in HER-2 overexpressing metastatic breast cancer: a multicenter phase II trial.
    Chia S; Clemons M; Martin LA; Rodgers A; Gelmon K; Pond GR; Panasci L
    J Clin Oncol; 2006 Jun; 24(18):2773-8. PubMed ID: 16682726
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Electrocardiographic changes after adriamycin chemotherapy.
    Ali MK; Soto A; Maroongroge D; Bekheit-Saad S; Buzdar AU; Blumenschein GR; Hortobagyi GN; Tashima CK; Wiseman CL; Shullenberger CC
    Cancer; 1979 Feb; 43(2):465-71. PubMed ID: 421174
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phase II clinical and pharmacological study of pirarubicin in combination with 5-fluorouracil and cyclophosphamide in metastatic breast cancer.
    Dhingra K; Frye D; Newman RA; Walters R; Theriault R; Fraschini G; Smith T; Buzdar A; Hortobagyi GN
    Clin Cancer Res; 1995 Jul; 1(7):691-7. PubMed ID: 9816034
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adjuvant chemotherapy with doxorubicin plus cyclophosphamide, methotrexate, and fluorouracil in the treatment of resectable breast cancer with more than three positive axillary nodes.
    Buzzoni R; Bonadonna G; Valagussa P; Zambetti M
    J Clin Oncol; 1991 Dec; 9(12):2134-40. PubMed ID: 1960555
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Heart failure in a breast cancer survivor.
    Moore S
    Oncol Nurs Forum; 2012 Mar; 39(2):147-50. PubMed ID: 22374488
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.